Policy | June 12, 2026
Biopharma SHAKTI envisages launch of 100 biologics by 2047: Anupriya Patel
The union minister spoke at the 2nd Pharma Summit & Awards 2026 organised by ASSOCHAM in New Delhi
The union minister spoke at the 2nd Pharma Summit & Awards 2026 organised by ASSOCHAM in New Delhi
SENS study to assess feasibility, effectiveness and family experience of introducing SMA screening into the NHS newborn screening programme
Company experts to participate in eight sessions covering AI-powered clinical development, regulatory innovation, oncology research, and patient engagement
The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients
First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe
Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio
The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities
Bengaluru-based startup will use the fresh capital to enter new markets, enhance technology capabilities, and scale its integrated care model
Consolidated entity plans to strengthen specialty pharmaceutical offerings, expand manufacturing capacity, and accelerate global market penetration across emerging regions
The company will present 21 oral and poster presentations spanning investigational and approved therapies
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
